The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
HIF-1α influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination
Open accessAbstract
Hypoxia-inducible factor (HIF)-1 is a transcription factor known to play an important role in regulating the innate immune response to infection. Under baseline conditions, cellular HIF-1 levels in leukocytes are scarce, but levels rise rapidly in response to hypoxia or molecular signals of infection or inflammation such as microbial surface molecules and host-derived cytokines. Innate immune cells such as macrophages, neutrophils, and mast cells exhibit increased microbicidal activity when HIF-1 levels are increased, and mice lacking HIF-1 are more susceptible to invasive bacterial infection. In this study, we used genetic and pharmacologic means to determine whether HIF-1 also plays an important role in the adaptive immune response to infection. HIF-1α/Tie-2 Cre(+) mice harboring a >90 % knockdown of HIF-1 in myeloid cells were studied. We found antigen-presenting cells from these mice that expressed lower levels of MHC-II and the costimulatory molecules CD80 and CD86, and were less able to induce T cell proliferation. These differences were present at baseline and persisted after activation. Increasing HIF-1 levels in wild-type (WT) cells by using the prolyl hydroxylase inhibitor drug AKB-4924 had the opposite effect, increasing MHC and costimulatory molecule expression and T cell proliferation. In experimental vaccination, HIF-1α/Tie-2 Cre(+) mice exhibited a weaker T cell response and lower antibody levels in response to vaccination than WT mice, while WT mice treated with a drug to elevate HIF-1 responded more strongly to vaccination. Thus, HIF-1 participates in bridging the innate and adaptive immune responses and may merit further exploration as an adjuvant target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This observation conforms to findings that HIF1 a promotes LPS-induced maturation of DC (Bhandari et al., 2013; Jantsch et al., 2008).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Bhandari et al., 2013
In the citing paper
“In dendritic cells (DC), HIF1 a supports maturation, activation, migration, and antigen presentation (Bhandari et al., 2013; Jantsch et al., 2008; Ko ¨ hler et al., 2012; Pantel et al., 2014).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Bhandari et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2×
“HIF is a basic helix–loop–helix transcription factor [3] first identified because of its role in erythropoietin regulation [4].”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“AKB-4924 inhibits the prolyl hydroxylases [28] that negatively regulate HIF-1α [29] and preferentially elevates HIF-1α over HIF-1β [28].”
BackgroundSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Self-citationIntegration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941
Self-citationGu, Y.-Z., Moran, S. M., Hogenesch, J. B., Wartman, L. D., & Bradfield, C. A. (1998) · Europe PMC (PubMed Central) · Cited by 771
HIF-1α expression regulates the bactericidal capacity of phagocytes
Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A., Theodorakis, E. A., Gallo, R. L., Hurtado-Ziola, N., Nizet, V., & Johnson, R. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23865 · Cited by 702
Self-citationJung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
BLANCO, P., PALUCKA, A., PASCUAL, V, & BANCHEREAU, J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.004 · Cited by 566
Tang, N., Wang, L., Esko, J., Giordano, F. J., Huang, Y., Gerber, H.-P., Ferrara, N., & Johnson, R. S. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.026 · Cited by 540
Self-citationSodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., & Gutkind, J. S. (2000) · PubMed · Cited by 516
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & Jelkmann, W. (1999) · Blood · doi:10.1182/blood.v94.5.1561 · Cited by 475
Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B., Gerlach, R. G., Volke, M., Gläsner, J., Warnecke, C., Wiesener, M. S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4697 · Cited by 414
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Bernhardt, W. M., Wiesener, M. S., Scigalla, P., Chou, J., Schmieder, R. E., Günzler, V., & Eckardt, K.-U. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010116 · Cited by 340
Hara, S., Hamada, J., Kobayashi, C., Kondo, Y., & Imura, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5659 · Cited by 282
Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1α
Wakisaka, N., Kondo, S., Yoshizaki, T., Murono, S., Furukawa, M., & Pagano, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5223-5234.2004 · Cited by 204
Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1α-dependent manner
Anand, R. J., Gribar, S. C., Li, J., Kohler, J. W., Branca, M. F., Dubowski, T., Sodhi, C. P., & Hackam, D. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307195 · Cited by 192
Divergent effects of hypoxia on dendritic cell functions
Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I.-H., Sozzani, S., Austyn, J. M., Mantovani, A., & Sica, A. (2008) · Blood · doi:10.1182/blood-2008-02-142091 · Cited by 184
Activation of hypoxia-inducible factor 1 during macrophage differentiation
Oda, T., Hirota, K., Nishi, K., Takabuchi, S., Oda, S., Yamada, H., Arai, T., Fukuda, K., Kita, T., Adachi, T., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00614.2005 · Cited by 138
Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis
Mecklenburgh, K. I., Walmsley, S. R., Cowburn, A. S., Wiesener, M. S., Reed, B. J., Upton, P. D., Deighton, J., Greening, A. P., & Chilvers, E. R. (2002) · Blood · doi:10.1182/blood-2002-02-0454 · Cited by 126
HIF-1 : a master regulator of innate host defenses?
Zarember, K. A., & Malech, H. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25740 · Cited by 120
Okumura, C. Y. M., Hollands, A., Tran, D. N., Olson, J., Dahesh, S., von Köckritz-Blickwede, M., Thienphrapa, W., Corle, C., Jeung, S. N., Kotsakis, A., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0882-3 · Cited by 115 · cited 3×
“7 macrophages, showing that when HIF levels are increased with the HIF-1α-boosting drug AKB-4924 [28], the macrophages express higher levels of MHC-II, CD80, and CD86 (Fig.”
BackgroundSelf-citationAcosta‐Iborra, B., Elorza, A., Olazabal, I. M., Martin-Cofreces, N. B., Martín-Puig, S., Miró, M., Calzada, M. J., Aragonés, J., Sánchez‐Madrid, F., & Landázuri, M. O. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801710 · Cited by 110
Jantsch, J., Wiese, M., Schödel, J., Castiglione, K., Gläsner, J., Kolbe, S., Mole, D., Schleicher, U., Eckardt, K.-U., Hensel, M., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210683 · Cited by 108
Elia, A. R., Cappello, P., Puppo, M., Fraone, T., Vanni, C., Eva, A., Musso, T., Novelli, F., Varesio, L., & Giovarelli, M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208082 · Cited by 106
Yang, M., Ma, C., Liu, S., Sun, J., Shao, Q., Gao, W., Zhang, Y., Li, Z., Xie, Q., Dong, Z., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02954.x · Cited by 102
Transcriptome of Hypoxic Immature Dendritic Cells: Modulation of Chemokine/Receptor Expression
Ricciardi, A., Elia, A. R., Cappello, P., Puppo, M., Vanni, C., Fardin, P., Eva, A., Munroe, D. J., Wu, X., Giovarelli, M., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0391 · Cited by 102
Spirig, R., Djafarzadeh, S., Regueira, T., Shaw, S., von Garnier, C., Takala, J. A., Jakob, S. M., Rieben, R., & Lepper, P. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010983 · Cited by 88
Hypoxia: a double-edged sword of immunity
Sica, A., Melillo, G., & Varesio, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0724-8 · Cited by 67
Reoxygenation of hypoxia-differentiated dentritic cells induces Th1 and Th17 cell differentiation
Wang, Q., Liu, C., Zhu, F., Liu, F., Zhang, P., Guo, C., Wang, X., Li, H., Ma, C., Sun, W., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.09.038 · Cited by 53
Tissue PO2 Changes in Acute Inflammation
Silver, I. A. (1978) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-8890-6_106 · Cited by 43
Cited by
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195
“…with a PHD inhibitor increased major histocompatibility complex (MHC) and costimulatory molecule expression by DCs, which in turn induced greater T cell proliferation , serving to produce higher titers of antibodies on immunization with the model antigen ovalbumin (Bhandari et al., 2013).”
BackgroundSelf-citationHypoxia‐inducible factors in regulation of immune responses in tumour microenvironment
Kumar, V., & Gabrilovich, D. I. (2014) · Immunology · doi:10.1111/imm.12380 · Cited by 329
Pantel, A., Teixeira, A., Haddad, E., Wood, E. G., Steinman, R. M., & Longhi, M. P. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001759 · Cited by 209
Wilson, G. K., Tennant, D. A., & McKeating, J. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.025 · Cited by 204
Metadata
- Authors
- Bhandari, T., Olson, J., Johnson, R. S., & Nizet, V.
- Affiliations
- University of California San Diego (US)
- University of Cambridge (GB)
- Corresponding author
- Nizet, Victor
- Venue
- Journal of Molecular Medicine
- Published
- 2013-05-19
- Volume
- 91
- Issue
- 10
- Pages
- 1199-1205
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- PMC
- PMC3783576
- OpenAlex
- W2113299134
- Cited by
- 47
- References
- 34
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 8 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 8
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (092738/Z/10/Z, 092738)
- National Institutes of Health
- U.S. Public Health Service (T32 062496, 093451, T32 007752, 090863)
- University of California, San Diego
- National Institute of General Medical Sciences (T32GM007752)
- National Institute of Allergy and Infectious Diseases (R01AI093451, R56AI090863)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR062496)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- HIF-1α, myeloid cells, antigen presentation, MHC class II, costimulatory molecules, CD80, CD86, T cell proliferation, prolyl hydroxylase inhibitors, innate-adaptive immune crosstalk, vaccine adjuvants, hypoxia
- MeSH terms
- Animals, Dendritic Cells, Immunity, Innate, Injections, Subcutaneous, Lymphocyte Activation, Macrophages, Ovalbumin, Piperazines, Pyridones, Vaccination, T-Lymphocyte Subsets, Cytokines, Antigen Presentation, Mice, Knockout, Myeloid Cells, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.